Peng, J., Yang, J., Antonopoulou, G., Fang, R., Adhikari, B., Vogt, M., Wolf, E., Sun, C., Du, S., Godfrey, L., Gupta, A., Trajkovic-Arsic, M., Teichmann, N., Grünwald, B. T., Krebs, N., Steiger, K., Mogler, C., Althoff, K., Wang, X., Giglio, G., Liffers, S., Savvatakis, K., Braren, R., Lawlor, R. T., Scarpa, A., Behrens, D., Lang, K. S., Cheung, P. F., Siveke, J. T. (2026). Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma. Nature Communications. https://doi.org/10.1038/s41467-026-69013-y